Hirsutism in Women

Area of Science:

• Endocrinology
• Dermatology

Background:

• Hirsutism is defined as excessive terminal hair growth in a male pattern on a female, frequently signaling elevated androgen levels.
• Polycystic ovary syndrome (PCOS) and idiopathic hyperandrogenism are the leading causes, representing over 85% of cases.
• Other potential causes include nonclassic congenital adrenal hyperplasia, androgen-secreting tumors, and endocrine disorders like Cushing syndrome or thyroid dysfunction.

Purpose of the Study:

• To provide a comprehensive overview of hirsutism, encompassing its causes, diagnostic approaches, and therapeutic strategies.
• To highlight the importance of evaluating elevated androgen levels in women presenting with abnormal hirsutism scores.
• To emphasize the need for timely diagnosis, especially in cases of rapid onset or virilization, which may indicate androgen-secreting tumors.

Main Methods:

• Assessment of hirsutism typically involves the Ferriman-Gallwey scoring system to quantify hair growth.
• Diagnostic evaluation includes biochemical testing for androgen levels to identify underlying causes.
• Review of current pharmacologic therapies and hair removal techniques for managing hirsutism.

Main Results:

• Elevated androgen levels are a key indicator for women with abnormal hirsutism scores.
• Rapid onset of hirsutism or signs of virilization warrant immediate investigation for androgen-secreting tumors.
• Pharmacologic treatments like combined oral contraceptives, finasteride, spironolactone, and topical eflornithine are effective, requiring at least six months of use.

Conclusions:

• Hirsutism necessitates a thorough evaluation to determine the underlying cause, with PCOS being the most prevalent.
• Prompt diagnosis and management are essential, particularly when suspecting serious conditions like androgen-secreting tumors.
• A combination of pharmacologic therapy and hair removal methods offers effective, albeit sometimes temporary or costly, management options.